The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Apogepha
Research Funding - Curie Therapeutics; Novartis
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; R & D Systems Inc.
68Ga-FAPI-46 PET/CT for cancer imaging: Results of a single-center, prospective, interventional, single-arm clinical trial.
 
Kim Pabst
Consulting or Advisory Role - GE Healthcare; Novartis
Research Funding - Bayer Germany
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Timo Bartel
Consulting or Advisory Role - Novartis
 
Patrick Sandach
No Relationships to Disclose
 
Christina Laschinsky
Travel, Accommodations, Expenses - Novartis
 
Manuel Weber
No Relationships to Disclose
 
Lukas Kessler
No Relationships to Disclose
 
Alina Küper
No Relationships to Disclose
 
Boris Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Accord Healthcare; Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis; Onkowissen; Pfizer; POINT Biopharma
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; BMS; Ipsen; Janssen
(OPTIONAL) Uncompensated Relationships - German Association of Urology
 
Claudia Kesch
No Relationships to Disclose
 
Rainer Hamacher
No Relationships to Disclose
 
Stefan Kasper
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Incyte; Lilly; Merck Serone; MSD; Roche; Sanofi Aventis GmbH; SERVIER
 
Lars Podleska
No Relationships to Disclose
 
Jens Siveke
Stock and Other Ownership Interests - FAPI Holding
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Immunocore; Merck Sharp & Dohme; Novartis; Roche/Genentech; SERVIER
Research Funding - Abalos Therapeutics (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisbach Bio (Inst); Roche/Genentech (Inst)
 
Markus Eckstein
Employment - Diaceutics
Honoraria - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; Owkin; Roche
Consulting or Advisory Role - AstraZeneca; Diaceutics; Genomic Health; Gilead Sciences; Janssen-Cilag; MSD Oncology; Owkin
Speakers' Bureau - Astellas Pharma; AstraZeneca; Diaceutics; MSD; Roche
Research Funding - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Gilead Sciences; Janssen; Owkin; STRATIFYER Molecular Pathology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; MSD; Roche
 
Bastian von Tresckow
Honoraria - Abbvie; Abbvie; AstraZeneca; BMS; Incyte; Kite, a Gilead company; Lilly; MSD; Novartis; Roche; Roche Pharma AG; Takeda
Consulting or Advisory Role - Alimera Sciences; Amgen; Bristol-Myers Squibb/Celgene; Cerus; Incyte; IQVIA; Janssen-Cilag GmbH; Kite/Gilead; Lilly; Miltenyi Biotec; MSD; Noscendo; Novartis; Pentixapharm; Pfizer; Pierre Fabre; Qualworld; Regeneron; Roche; SOBI; Takeda
Research Funding - Esteve (Inst); MSD (Inst); Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AbbVie; AstraZeneca; Kite/Gilead; Lilly; MSD; Novartis; Pierre Fabre; Roche; Takeda
 
Sherko Kuemmel
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Hologic; Lilly; MSD Oncology; Novartis; Pfizer; PINK; Roche/Genentech; Seagen; Sonoscape; Stemline Therapeutics; Stryker
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Roche
(OPTIONAL) Uncompensated Relationships - West German Study Group
 
Anke Reinacher-Schick
No Relationships to Disclose
 
Waldemar Uhl
No Relationships to Disclose
 
Ken Herrmann
Leadership - Aktis Oncology; Pharma15
Stock and Other Ownership Interests - AdvanCell; Aktis Oncology; Convergent Therapeutics; SOFIE
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bain Capital; Bayer; Boston Scientific; BTG; Debiopharm Group; Fusion Pharmaceuticals; GE Healthcare; Immedica; IPSEN; ITG (Inst); Janssen Oncology; Molecular Partners; Novartis; Radiopharm Theranostics; ROTOP Pharmaka (Inst); Siemens Healthineers; Telix Pharmaceuticals
 
Wofgang Fendler
Consulting or Advisory Role - Bayer; Calyx; Janssen; Novartis
Speakers' Bureau - ABX Advanced biochemical compounds; Amgen; Bayer; Eczacibasi-Monrol; GE Healthcare; Janssen; Novartis; Telix Pharmaceuticals
Research Funding - Bayer; SOFIE